67/100B146.710
USD
-0.21
(-0.14%)
Post Trading·146.910USD+0.200(+0.14%)
Last updated: · Delayed 15 min
Fair valueNot reliable
Q4 FY2026 · Earnings report
EPS estimate 1.78Revenue estimate 16.29B
Q4 FY2026 · Earnings report
EPS estimate 1.78Revenue estimate 16.29B
Merck & Co executives and insider trading
Robert Davis reported no open-market purchases or sales over the last twelve months.
Over the last twelve months Merck & Co's insiders sold 194,076 shares for 25.58M USD in 13 sales on the open market, and bought 0 shares in 0 purchases.
Insiders over the last twelve months
- Insider sales
- 13
- Shares sold
- 194,076
- Value sold
- 25.58M USD
- Insider purchasesWhat is insider trading? Insider trading here means the legal trades that a company's executives, directors and large owners make in its shares, reported to the SEC on Form 4.
- 0
Insiders buying against sellingWhat is a Rule 10b5-1 trading plan? A Rule 10b5-1 plan lets an insider fix future trades in advance, while holding no inside information, so later trades follow the plan, not a new decision.
Bought on the market
Sold on the market
0
1 week
0
0
1 month
0
0
3 months
18.01M USD
0
6 months
25.58M USD
0
1 year
25.58M USD
0
2 years
25.58M USD
Sold, decided at the timeSold under a Rule 10b5-1 plan set in advance
Open-market purchases and sales reported on Form 4, by value. Awards, option exercises and shares withheld for tax are not counted. Whether a sale was under a Rule 10b5-1 plan is read from each Form 4 at the SEC (the box exists on filings since April 2023).
Executives and directors
The people who run the company and the directors who reported trades, with what each bought and sold on the open market over the last twelve months. The CEO first, then whoever traded most.
| Name | Position | Age | Shares sold (12 months) | Value sold (12 months) | Shares bought (12 months) | Last sale | Shares held after |
|---|---|---|---|---|---|---|---|
| Robert Davis CEO | Chairman, President & Chief Executive Officer | 59 | — | — | — | — | — |
| Jennifer L. Zachary | Executive Vice President & General Counsel | 48 | 80,315 | 10.72M USD | — | 12 Aug 2026 | 125,824 |
| Richard R. DeLuca Jr. | Executive Vice President & President of Merck Animal Health | 63 | 51,370 | 6.73M USD | — | 12 Aug 2026 | 110,767 |
| David Michael Williams | Executive Vice President and Chief Information & Digital Officer | 57 | 34,705 | 4.47M USD | — | 5 Aug 2026 | 66,421 |
| Chirfi Guindo | Executive Vice President of Strategic Access, Policy & Communications | 60 | 25,000 | 3.32M USD | — | 13 Aug 2026 | 36,613 |
| David R. Maraldo | EVP & Pres. MMD | — | 2,686 | 345.74K USD | — | 5 Aug 2026 | 27,921 |
| Dean Y. Li | Executive Vice President & President of Merck Research Laboratories | 63 | — | — | — | — | — |
| Gaurav K. Gupta | Executive Vice President and Chief Information & Digital Officer | — | — | — | — | — | 750 |
| Betty D. Larson | Executive Vice President & Chief Human Resources Officer | 50 | — | — | — | — | — |
| Caroline Litchfield | Executive Vice President & Chief Financial Officer | 57 | — | — | — | — | — |
| Dalton E. Smart | Senior Vice President of Finance, Principal Accounting Officer & Global Controller | 59 | — | — | — | — | 9,520 |
| Peter Dannenbaum | Vice President of Investor Relations | — | — | — | — | — | — |
| Paul J Diaz | Director | — | — | — | — | — | 200 |
| Christine E Seidman | Director | — | — | — | — | — | — |
| Surendralal Lanca Karsanbhai | Director | — | — | — | — | — | — |
| Mary Ellen Coe | Director | — | — | — | — | — | — |
| Kathy J Warden | Director | — | — | — | — | — | — |
| Inge G Thulin | Director | — | — | — | — | — | — |
| Patricia F Russo | Director | — | — | — | — | — | — |
| Paul Rothman | Director | — | — | — | — | — | — |
| Stephen Mayo | Director | — | — | — | — | — | — |
| Risa J Lavizzo-mourey | Director | — | — | — | — | — | — |
| Thomas H Glocer | Director | — | — | — | — | — | — |
| Pamela J. Craig | Director | — | — | — | — | — | — |
| Douglas M Jr Baker | Director | — | — | — | — | — | — |
| Brian Foard | EVP, Specialty, Pharma, & ID | — | — | — | — | — | — |
| Johannes Jacobus Oosthuizen | EVP, Oncology & Int?l | — | — | — | — | — | — |
| Sanat Chattopadhyay | Exe V-P & Pres. MMD | — | — | — | — | — | 16,477 |
Insider sales and purchases by quarter
How many insider sales and purchases were reported each quarter.
Insider sales Insider purchases
Every insider transactionWhat is insider trading? Insider trading here means the legal trades that a company's executives, directors and large owners make in its shares, reported to the SEC on Form 4.
Insiders must report every trade in the company's shares to the SEC within two business days, on Form 4. Only purchases and sales are trades on the open market; awards, option exercises, shares withheld for tax and gifts come with pay, and the twelve-month totals leave them out.
| Date | Name | Transaction | Shares | Price | Value | Shares held after | Filing |
|---|---|---|---|---|---|---|---|
| 7 Aug 2027 | Gaurav K. Gupta | Other | 19,443 | — | — | — | Form 4 |
| 1 Nov 2026 | Paul J Diaz | Award | 613 | — | — | 613 | Form 4 |
| 1 Nov 2026 | Paul J Diaz | Other | — | — | — | 200 | Form 4 |
| 1 Nov 2026 | Paul J Diaz | Other | — | — | — | 96 | Form 4 |
| 30 Sept 2026 | Christine E Seidman | Award | 56 | — | — | 21,490 | Form 4 |
| 30 Sept 2026 | Surendralal Lanca Karsanbhai | Award | 112 | — | — | 5,667 | Form 4 |
| 30 Sept 2026 | Mary Ellen Coe | Award | 206 | — | — | 32,420 | Form 4 |
| 1 Sept 2026 | Gaurav K. Gupta | Other | — | — | — | 750 | Form 4 |
| 13 Aug 2026 | Chirfi Guindo | Sale | 10,000 | 135.00 | 1.35M USD | 36,613 | Form 4 |
| 12 Aug 2026 | Jennifer L. Zachary | Option exercise | 13,433 | 84.71 | 1.14M USD | 125,824 | Form 4 |
| 12 Aug 2026 | Jennifer L. Zachary | Option exercise | 41,494 | 117.89 | 4.89M USD | 112,391 | Form 4 |
| 12 Aug 2026 | Jennifer L. Zachary | Sale | 80,315 | 133.46 | 10.72M USD | 45,509 | Form 4 |
| 12 Aug 2026 | Jennifer L. Zachary | Option exercise | 13,433 | 84.71 | 1.14M USD | — | Form 4 |
| 12 Aug 2026 | Jennifer L. Zachary | Option exercise | 41,494 | 117.89 | 4.89M USD | — | Form 4 |
| 12 Aug 2026 | Richard R. DeLuca Jr. | Sale | 11,099 | 131.61 | 1.46M USD | 110,767 | Form 4 |
| 12 Aug 2026 | Richard R. DeLuca Jr. | Sale | 600 | 132.04 | 79.22K USD | 110,167 | Form 4 |
| 11 Aug 2026 | Richard R. DeLuca Jr. | Sale | 7,410 | 131.33 | 973.16K USD | 127,293 | Form 4 |
| 11 Aug 2026 | Richard R. DeLuca Jr. | Sale | 5,427 | 132.35 | 718.26K USD | 121,866 | Form 4 |
| 10 Aug 2026 | Richard R. DeLuca Jr. | Sale | 20,784 | 130.43 | 2.71M USD | 134,703 | Form 4 |
| 6 Aug 2026 | Richard R. DeLuca Jr. | Sale | 805 | 131.02 | 105.47K USD | 160,732 | Form 4 |
| 6 Aug 2026 | Richard R. DeLuca Jr. | Sale | 4,945 | 130.23 | 643.99K USD | 155,787 | Form 4 |
| 6 Aug 2026 | Richard R. DeLuca Jr. | Sale | 300 | 131.02 | 39.31K USD | 155,487 | Form 4 |
| 6 Aug 2026 | Chirfi Guindo | Sale | 15,000 | 131.00 | 1.97M USD | 46,613 | Form 4 |
| 5 Aug 2026 | David R. Maraldo | Option exercise | 9,709 | 87.10 | 845.65K USD | 27,921 | Form 4 |
| 5 Aug 2026 | David R. Maraldo | Option exercise | 6,311 | 73.73 | 465.31K USD | 24,523 | Form 4 |
| 5 Aug 2026 | David R. Maraldo | Option exercise | 2,686 | 84.71 | 227.53K USD | 20,898 | Form 4 |
| 5 Aug 2026 | David R. Maraldo | Sale | 2,686 | 128.72 | 345.74K USD | 18,212 | Form 4 |
| 5 Aug 2026 | David R. Maraldo | Option exercise | 2,686 | 84.71 | 227.53K USD | 5,374 | Form 4 |
| 5 Aug 2026 | David R. Maraldo | Option exercise | 6,311 | 73.73 | 465.31K USD | 3,154 | Form 4 |
| 5 Aug 2026 | David R. Maraldo | Option exercise | 9,709 | 87.10 | 845.65K USD | — | Form 4 |
| 5 Aug 2026 | David Michael Williams | Option exercise | 34,705 | 73.73 | 2.56M USD | 66,421 | Form 4 |
| 5 Aug 2026 | David Michael Williams | Option exercise | 13,542 | 75.36 | 1.02M USD | 45,258 | Form 4 |
| 5 Aug 2026 | David Michael Williams | Option exercise | 4,600 | 77.62 | 357.05K USD | 36,316 | Form 4 |
| 5 Aug 2026 | David Michael Williams | Sale | 34,705 | 128.77 | 4.47M USD | 31,716 | Form 4 |
| 5 Aug 2026 | David Michael Williams | Option exercise | 4,600 | 77.62 | 357.05K USD | — | Form 4 |
| 5 Aug 2026 | David Michael Williams | Option exercise | 13,542 | 75.36 | 1.02M USD | — | Form 4 |
| 5 Aug 2026 | David Michael Williams | Option exercise | 34,705 | 73.73 | 2.56M USD | — | Form 4 |
| 30 Jun 2026 | Christine E Seidman | Award | 63 | — | — | 21,291 | Form 4 |
| 30 Jun 2026 | Surendralal Lanca Karsanbhai | Award | 126 | — | — | 5,519 | Form 4 |
| 30 Jun 2026 | Mary Ellen Coe | Award | 233 | — | — | 31,999 | Form 4 |
| 29 May 2026 | Kathy J Warden | Award | 1,853 | — | — | 17,890 | Form 4 |
| 29 May 2026 | Surendralal Lanca Karsanbhai | Award | 1,853 | — | — | 5,392 | Form 4 |
| 29 May 2026 | Mary Ellen Coe | Award | 1,853 | — | — | 31,766 | Form 4 |
| 29 May 2026 | Inge G Thulin | Award | 1,853 | — | — | 27,470 | Form 4 |
| 29 May 2026 | Christine E Seidman | Award | 1,853 | — | — | 21,228 | Form 4 |
| 29 May 2026 | Patricia F Russo | Award | 1,853 | — | — | 62,391 | Form 4 |
| 29 May 2026 | Paul Rothman | Award | 1,853 | — | — | 34,945 | Form 4 |
| 29 May 2026 | Stephen Mayo | Award | 1,853 | — | — | 14,825 | Form 4 |
| 29 May 2026 | Risa J Lavizzo-mourey | Award | 1,853 | — | — | 17,749 | Form 4 |
| 29 May 2026 | Thomas H Glocer | Award | 1,853 | — | — | 110,912 | Form 4 |
| 29 May 2026 | Pamela J. Craig | Award | 1,853 | — | — | 34,945 | Form 4 |
| 29 May 2026 | Douglas M Jr Baker | Award | 1,853 | — | — | 11,518 | Form 4 |
| 5 May 2026 | Jennifer L. Zachary | Award | 35,312 | 113.15 | 4.00M USD | 35,312 | Form 4 |
| 5 May 2026 | Jennifer L. Zachary | Award | 12,064 | — | — | 12,064 | Form 4 |
| 5 May 2026 | David Michael Williams | Award | 13,582 | 113.15 | 1.54M USD | 13,582 | Form 4 |
| 5 May 2026 | David Michael Williams | Award | 4,640 | — | — | 4,640 | Form 4 |
| 5 May 2026 | Caroline Litchfield | Award | 46,566 | 113.15 | 5.27M USD | 46,566 | Form 4 |
| 5 May 2026 | Caroline Litchfield | Award | 15,908 | — | — | 15,908 | Form 4 |
| 5 May 2026 | Dean Y. Li | Award | 58,207 | 113.15 | 6.59M USD | 58,207 | Form 4 |
| 5 May 2026 | Dean Y. Li | Award | 19,885 | — | — | 19,885 | Form 4 |
| 5 May 2026 | Betty D. Larson | Award | 23,283 | 113.15 | 2.63M USD | 23,283 | Form 4 |
| 5 May 2026 | Betty D. Larson | Award | 7,954 | — | — | 7,954 | Form 4 |
| 5 May 2026 | Richard R. DeLuca Jr. | Award | 34,924 | 113.15 | 3.95M USD | 34,924 | Form 4 |
| 5 May 2026 | Richard R. DeLuca Jr. | Award | 11,931 | — | — | 11,931 | Form 4 |
| 5 May 2026 | Robert Davis | Award | 139,697 | 113.15 | 15.81M USD | 139,697 | Form 4 |
| 5 May 2026 | Robert Davis | Award | 47,724 | — | — | 47,724 | Form 4 |
| 5 May 2026 | Brian Foard | Award | 35,351 | — | — | 35,351 | Form 4 |
| 5 May 2026 | Brian Foard | Award | 31,044 | 113.15 | 3.51M USD | 31,044 | Form 4 |
| 5 May 2026 | Brian Foard | Award | 10,605 | — | — | 10,605 | Form 4 |
| 5 May 2026 | David R. Maraldo | Award | 21,731 | 113.15 | 2.46M USD | 21,731 | Form 4 |
| 5 May 2026 | David R. Maraldo | Award | 7,424 | — | — | 7,424 | Form 4 |
| 5 May 2026 | Johannes Jacobus Oosthuizen | Award | 31,044 | 113.15 | 3.51M USD | 31,044 | Form 4 |
| 5 May 2026 | Johannes Jacobus Oosthuizen | Award | 10,605 | — | — | 10,605 | Form 4 |
| 5 May 2026 | Dalton E. Smart | Award | 5,045 | 113.15 | 570.84K USD | 5,045 | Form 4 |
| 5 May 2026 | Dalton E. Smart | Award | 2,298 | — | — | 2,298 | Form 4 |
| 5 May 2026 | Chirfi Guindo | Award | 19,402 | 113.15 | 2.20M USD | 19,402 | Form 4 |
| 5 May 2026 | Chirfi Guindo | Award | 6,628 | — | — | 6,628 | Form 4 |
| 2 May 2026 | Dalton E. Smart | Option exercise | 383 | 112.16 | 42.96K USD | 9,520 | Form 4 |
| 2 May 2026 | Dalton E. Smart | Shares withheld for tax | 132 | 112.16 | 14.81K USD | 9,388 | Form 4 |
| 2 May 2026 | Dalton E. Smart | Option exercise | 383 | — | — | — | Form 4 |
| 2 May 2026 | David R. Maraldo | Option exercise | 552 | 112.16 | 61.91K USD | 18,371 | Form 4 |
| 2 May 2026 | David R. Maraldo | Shares withheld for tax | 159 | 112.16 | 17.83K USD | 18,212 | Form 4 |
| 2 May 2026 | David R. Maraldo | Option exercise | 552 | — | — | — | Form 4 |
| 1 May 2026 | David R. Maraldo | Other | — | — | — | 2,871 | Form 4 |
| 1 May 2026 | David R. Maraldo | Other | — | — | — | 17,819 | Form 4 |
| 1 May 2026 | David R. Maraldo | Other | — | — | — | 8,359 | Form 4 |
| 29 Apr 2026 | David R. Maraldo | Other | 2,361 | — | — | — | Form 4 |
| 29 Apr 2026 | David R. Maraldo | Other | 8,060 | 84.71 | 682.76K USD | — | Form 4 |
| 29 Apr 2026 | Chirfi Guindo | Option exercise | 1,967 | 110.03 | 216.43K USD | 62,582 | Form 4 |
| 29 Apr 2026 | Chirfi Guindo | Shares withheld for tax | 969 | 110.03 | 106.62K USD | 61,613 | Form 4 |
| 29 Apr 2026 | Chirfi Guindo | Option exercise | 1,967 | — | — | 3,935 | Form 4 |
| 29 Apr 2026 | Sanat Chattopadhyay | Option exercise | 2,597 | 110.03 | 285.75K USD | 16,477 | Form 4 |
| 29 Apr 2026 | Sanat Chattopadhyay | Shares withheld for tax | 1,130 | 110.03 | 124.33K USD | 15,347 | Form 4 |
| 29 Apr 2026 | Sanat Chattopadhyay | Option exercise | 2,597 | — | — | 5,194 | Form 4 |
| 29 Apr 2026 | Richard R. DeLuca Jr. | Option exercise | 2,518 | 110.03 | 277.06K USD | 162,778 | Form 4 |
| 29 Apr 2026 | Richard R. DeLuca Jr. | Shares withheld for tax | 1,241 | 110.03 | 136.55K USD | 161,537 | Form 4 |
| 30 Apr 2025 | David R. Maraldo | Other | 8,789 | 129.22 | 1.14M USD | — | Form 4 |
Common questions about Merck & Co's executives and insiders
Source: Financial Modeling Prep